The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 6.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (4 analysts) rates it none, with a mean price target of $35.
ICICI Bank IBN
Outside both standards
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · ICICI Bank Limited, together with its subsidiaries, engages in the provision of various banking and financial services to retail and corporate customers in India and internationally.
read at $29.51
ICICI Bank holds its Markup at $29.51.
- PHPhase · the trend structure carries the Markup label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · does not pass the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markup |
| Quantitative state | The statistical read favours the sellers, held for 11 days |
| Price | $29.51 |
| Valuation | 18.33 trailing · 15.96 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 0.24 |
The opportunity · what the numbers say it is worth
Our framework reads AVOID — it trades at roughly a 8% discount to our $31.87 fair value, 11.40% revenue growth.
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Both our model and the analysts see meaningful upside from here.
| Revenue growth | 11.40% |
| Profit margin | 27.53% |
| Analyst consensus | Strong Buy · 4 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company is excluded by both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. It fails on both:
Used by most halal investing apps ✗ DOES NOT PASS
The one Titan applies ✗ DOES NOT PASS
Why it fails. The problem is its business activity exclusion: fail. Because both standards agree on this, it is a clear exclusion, not a borderline case.
What these two standards are, and how they differ →
- Business activity Business activity exclusion: FAIL Fail
- Debt load Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
- Interest-bearing cash Interest-bearing cash and securities are of assets, above the one-third limit. Fail
- Receivables Money owed to the company is of assets, above the 49% limit. Fail
- Revenue purity of revenue comes from non-compliant sources, over the 5% line. Fail
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Indian Bank Looks Strong but Fails Ethics
Millions of Indian households and businesses move money through ICICI every day, yet we are staying away. The business fails our ethical screen on activity exclusions, and that single point overrides everything else on the table.
Numbers show revenue growth at 67 percent, a 25 percent profit margin and 16 percent ROE, with shares changing hands at 15.6 times forward earnings. Analyst targets sit higher still, but none of that moves the needle once the ethical test is failed.
Risk sits with the hard exclusion itself plus normal emerging-market swings in regulation and currency. The screen exists for exactly these cases. Analysis, not advice.
| Forward P/E | 16.0x priced for continued growth |
| Trailing P/E | 18.3x reasonably valued |
| Revenue growth | 11.4% steady growth |
| Profit margin | 27.5% healthy profit margins |
| Return on equity | 16.1% a solid return on shareholder capital |
| Beta | 0.24 barely tracks the market's swings |
| Market cap | $105.8B |
The risks · The things to watch: its business and earnings are exposed to India and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Latest news · what the market is reading on IBN
- › ICICI Bank Q1 Earnings Call Highlights MarketBeat · 15d ago
- › India's ICICI Bank reports 15.9% rise in Q1 profit, beats estimates Reuters · 15d ago
- › IT, financials lead Indian benchmarks higher; Reliance, private banks up ahead of results Reuters · 16d ago
- › India's ICICI Lombard's quarterly profit falls Reuters · 18d ago
- › India's ICICI Prudential Life reports quarterly profit jump on strong premium growth Reuters · 18d ago
Headlines from third-party outlets, linked for reference — not our reporting, not advice.
Related securities · others in IBN's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
IBN trades on NYSE (ADR) (the company is based in India). As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (4 analysts) rates it none, with a mean price target of $35. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (4 analysts) rates it none, with a mean price target of $35. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (4 analysts) rates it none, with a mean price target of $35. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $26.10 | +2.5% | · | $1,025 | +2.5% |
| 2 months | $27.73 | -3.5% | · | $965 | -3.5% |
| 3 months | $26.82 | -0.3% | · | $998 | -0.3% |
| 6 months | $30.20 | -11.4% | · | $886 | -11.4% |
| 1 year | $33.16 | -19.3% | $0.26 | $815 | -18.5% |
| 2 years | $26.25 | +1.9% | $0.50 | $1,038 | +3.8% |
| 3 years | $22.42 | +19.3% | $0.69 | $1,224 | +22.4% |
| 5 years | $16.97 | +57.7% | $0.87 | $1,628 | +62.8% |
Historical returns from market close data. Past performance does not guarantee future results.